View prices & discounts
Free gifts
Request & accept offers online
Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant Human CXCL8 (IL-8) (50190PB) - Biotin - 50 µg | Login | Recombinant Human CXCL8 (IL-8) (50190PB) - Biotin - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| CX<sub>3</sub>CR1 (Extracellular Loop) Blocking Peptide - 50 µg | Login | CX<sub>3</sub>CR1 (Extracellular Loop) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| CX<sub>3</sub>CR1 (NT) Blocking Peptide - 50 µg | Login | CX<sub>3</sub>CR1 (NT) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| CXCR4 (Extracellular Loop) Blocking Peptide - 50 µg | Login | CXCR4 (Extracellular Loop) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| CXCR4 (NT) Blocking Peptide - 50 µg | Login | CXCR4 (NT) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Human Soluble CD40L (sCD40L) ELISA Development Kit | Login | Human Soluble CD40L (sCD40L) ELISA Development Kit | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human CD23 (Soluble) - 20 µg | Login | Recombinant Human CD23 (Soluble) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human CD27 - 100 µg | Login | Recombinant Human CD27 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human CD4 (Soluble) - 50 µg | Login | Recombinant Human CD4 (Soluble) - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human CD40 Ligand (aa 108-261) - 50 µg | Login | Recombinant Human CD40 Ligand (aa 108-261) - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mouse CD40 - 50 µg | Login | Recombinant Mouse CD40 - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human CD23 - 50 µg | Login | Recombinant Human CD23 - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Daxx (CT) Blocking Peptide - 50 µg | Login | Daxx (CT) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| TRAIL R3 (Extracellular Domain - 1) Blocking Peptide - 50 µg | Login | TRAIL R3 (Extracellular Domain - 1) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| TRAIL R3 (Extracellular Domain - 2) Blocking Peptide - 50 µg | Login | TRAIL R3 (Extracellular Domain - 2) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| TRAIL Receptor-1 (NT) Blocking Peptide - 50 µg | Login | TRAIL Receptor-1 (NT) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| TRAIL R4 (Intracellular Domain) Blocking Peptide - 50 µg | Login | TRAIL R4 (Intracellular Domain) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Ras Homolog Enriched in Brain (NT) Blocking Peptide - 50 µg | Login | Ras Homolog Enriched in Brain (NT) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Ras Homolog Enriched in Brain (Intermediate Domain) Blocking Pep - 50 µg | Login | Ras Homolog Enriched in Brain (Intermediate Domain) Blocking Pep - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| MyD88 (CT) Blocking Peptide - 50 µg | Login | MyD88 (CT) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| MyD88 (Intermediate Domain) Blocking Peptide - 50 µg | Login | MyD88 (Intermediate Domain) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| MyD88 (CT) Blocking Peptide - 50 µg | Login | MyD88 (CT) Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| IRF8 Blocking Peptide - 50 µg | Login | IRF8 Blocking Peptide - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human ICOS - 50 µg | Login | Recombinant Human ICOS - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mouse ICOS - 100 µg | Login | Recombinant Mouse ICOS - 100 µg | ||||||||||||||||
|
||||||||||||||||||
Contact
Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
50823 Cologne
Germany
T +49 221 126 02 66
F +49 221 126 02 67
